Publicaciones en colaboración con investigadores/as de University of Turin (13)

2026

  1. PRospective evaluation of the European Society of Cardiology 0/1h-algorithm`s safety and efficacy for triage of patients with suspected myocardial infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge cluster randomized controlled trial

    American Heart Journal, Vol. 292

2025

  1. Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC

    JTO Clinical and Research Reports, Vol. 6, Núm. 7

  2. Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry

    Frontiers in Medicine, Vol. 12

  3. Unsupervised clustering of intra-ventricular haemodynamic forces for the phenotyping of left ventricular function in non-ischaemic left ventricular cardiomyopathy

    European Heart Journal Cardiovascular Imaging, Vol. 26, Núm. 4, pp. 630-639

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 2, pp. 151-162

2021

  1. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    European Heart Journal, Vol. 42, Núm. 16, pp. 1545-1553

  2. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    EuroIntervention, Vol. 17, Núm. 5, pp. E367-E375

  3. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639

2019

  1. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

    European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195

2018

  1. Interplay between gut microbiota metabolism and inflammation in HIV infection

    ISME Journal, Vol. 12, Núm. 8, pp. 1964-1976